NEW YORK (GenomeWeb News) – Rosetta Genomics today announced the execution of an agreement with preferred provider organization MultiPlan for Rosetta's products, including the Rosetta Cancer Origin Test.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.
Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.
Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.
Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.